Publication | Closed Access

Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation

InfertilityFertilityHuman Chorionic GonadotropinReproductive HealthGynecologyPolycystic Ovary SyndromeFemale Reproductive SystemMenstrual CyclePublic HealthEndocrinologyMedicineOvarian HormoneVitro MaturationWomen's HealthHuman ReproductionReproductive Endocrinology